The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Recommended Principles and Practices for Validating Clinical Molecular Pathology Tests
Abstract
Context. —The use of DNA- and RNA-based tests continues to grow for applications as varied as inherited disease, infectious disease, cancer, identity testing, human leukocyte antigen typing, and pharmacogenetics. Progress is driven in part by the huge growth in knowledge about the molecular basis of disease coupled with advancements in technologic capabilities. In addition to requirements for clinical utility, every molecular test also may have limitations that must be carefully considered before clinical implementation. Analytic and clinical performance characteristics as well as test limitations are established and documented through the process of test validation. Objective. —To describe the established principles of test validation, along with relevant regulations in the United States, in order to provide a rational approach to introducing molecular tests into the clinical laboratory. Data Sources. —PubMed review of published literature, published guidelines, and online information from national and international professional organizations. Conclusions. —These resources and recommendations provide a framework for validating clinical tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Likelihood ratios with confidence: Sample size estimation for diagnostic test studies
Simel, D. L., Samsa, G. P., & Matchar, D. B. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90128-v · Cited by 932
A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis
Fischer, J. E., Bachmann, L. M., & Jaeschke, R. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1761-8 · Cited by 890
Cited by
Revisiting biomarker discovery by plasma proteomics
Geyer, P. E., Holdt, L. M., Teupser, D., & Mann, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20156297 · Cited by 917
ACMG clinical laboratory standards for next-generation sequencing
Rehm, H. L., Bale, S. J., Bayrak-Toydemir, P., Berg, J. S., Brown, K. K., Deignan, J. L., Friez, M. J., Funke, B. H., Hegde, M. R., & Lyon, E. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.92 · Cited by 907
Pascual, J., Attard, G., Bidard, F.-C., Curigliano, G., De Mattos-Arruda, L., Diehn, M., Italiano, A., Lindberg, J., Merker, J. D., Montagut, C., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.520 · Cited by 783
Validation of Laboratory-Developed Molecular Assays for Infectious Diseases
Burd, E. M. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-09 · Cited by 550
Li, T., Kung, H.-J., Mack, P. C., & Gandara, D. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3753 · Cited by 518
Metadata
- Authors
- Jennings, L., Van Deerlin, V. M., & Gulley, M. L.
- Venue
- Archives of Pathology & Laboratory Medicine
- Published
- 2009-05
- Volume
- 133
- Issue
- 5
- Pages
- 743-755
- ISSN
- 0003-9985 (ISSN-L)
- 1543-2165
- OpenAlex
- W2142480586
- Cited by
- 250
- References
- 2
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recommended Principles and Practices for Validating Clinical Molecular Pathology Tests. https://app.cochat.ai/papers/10.5858/133.5.743
- The paper
- Jennings, L., Van Deerlin, V. M., & Gulley, M. L. (2009). Recommended Principles and Practices for Validating Clinical Molecular Pathology Tests. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/133.5.743
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.